GSDME Is Related to Prognosis and Response to Chemotherapy in Oral Cancer

Ferroptosis-Strengthened Metabolic and Inflammatory Regulation of Tumor-Associated Macrophages Provokes Potent Tumoricidal Activities

(2021) Zhengying Gu et al.   NANO LETTERS

Novel prognostic model established for patients with head and neck squamous cell carcinoma based on pyroptosis-related genes

(2021) Yuchen Shen et al.   Translational Oncology

Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy

(2021) Yao Xiao et al.   Advanced Science

DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG

(2020) Omprakash Shriwas et al.   APOPTOSIS

Gasdermin E suppresses tumour growth by activating anti-tumour immunity

(2020) Zhibin Zhang et al.   NATURE

A bioorthogonal system reveals antitumour immune function of pyroptosis

(2020) Qinyang Wang et al.   NATURE

Prodrug‐Based Versatile Nanomedicine for Enhancing Cancer Immunotherapy by Increasing Immunogenic Cell Death

(2020) Shuang Bai et al.   Small

Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma

(2020) Shuo Wang et al.   ORAL DISEASES

mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells

(2020) T. Nakano et al.   JOURNAL OF DENTAL RESEARCH

Head and neck squamous cell carcinoma

(2020) Daniel E. Johnson et al.   Nature Reviews Disease Primers

A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma

(2019) Mengjiao Wu et al.   EBioMedicine

Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation

(2019) Corey Rogers et al.   Nature Communications

The role of pyroptosis in cancer: pro-cancer or pro-“host”?

(2019) Xiaojing Xia et al.   Cell Death & Disease

CD103+ T and Dendritic Cells Indicate a Favorable Prognosis in Oral Cancer

(2019) Y. Xiao et al.   JOURNAL OF DENTAL RESEARCH

Targeting CMTM6 suppresses stem cell-like properties and enhances antitumor immunity in head and neck squamous cell carcinoma

(2019) Lei Chen et al.   Cancer Immunology Research

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

(2018) Tathiane M. Malta et al.   CELL

Head and Neck Cancer in the New Era of Precision Medicine

(2018) J.E. Nör et al.   JOURNAL OF DENTAL RESEARCH

CD317 Signature in Head and Neck Cancer Indicates Poor Prognosis

(2018) L.-L. Yang et al.   JOURNAL OF DENTAL RESEARCH

Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin

(2017) Yupeng Wang et al.   NATURE

Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche

(2016) Olivier Govaere et al.   JOURNAL OF HEPATOLOGY

Pore-forming activity and structural autoinhibition of the gasdermin family

(2016) Jingjin Ding et al.   NATURE

Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update

(2015) Naoko Takebe et al.   Nature Reviews Clinical Oncology

Integrated Analysis of Transcriptomic and Proteomic Data

(2013) Saad Haider et al.   CURRENT GENOMICS

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma

(2013) Cong-Jun Wang et al.   MOLECULAR BIOLOGY REPORTS

Chemopreventive and Chemotherapeutic Actions of mTOR Inhibitor in Genetically Defined Head and Neck Squamous Cell Carcinoma Mouse Model

(2012) Z.-J. Sun et al.   CLINICAL CANCER RESEARCH

Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation

(2011) Y Bian et al.   ONCOGENE

Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis

(2008) Christine E. Eyler et al.   JOURNAL OF CLINICAL ONCOLOGY